UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional paid-in capital	Retained earnings (accumulated deficit)	Accumulated other comprehensive (loss)
Balance, beginning of period (in shares) at Dec. 31, 2022		82,436
Balance, beginning of period at Dec. 31, 2022	$ 130,843	$ 824	$ 229,602	$ (76,513)	$ (23,070)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for stock compensation plans (in shares)		452
Issuance of common stock for stock compensation plans	672	$ 4	668
Issuance of common stock under the employee stock purchase plan (in shares)		52
Issuance of common stock under the employee stock purchase plan	2,143	$ 1	2,142
Stock-based compensation	42,557		42,557
Cash dividends declared	(2,488)		(2,488)
Other comprehensive income (loss)	1,543				1,543
Net (loss)	(20,774)			(20,774)
Balance, end of period (in shares) at Mar. 31, 2023		82,940
Balance, end of period at Mar. 31, 2023	$ 154,496	$ 829	272,481	(97,287)	(21,527)
Balance, beginning of period (in shares) at Dec. 31, 2023	83,840	83,840
Balance, beginning of period at Dec. 31, 2023	$ 353,838	$ 838	379,584	(8,705)	(17,879)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for stock compensation plans (in shares)		1,139
Issuance of common stock for stock compensation plans	18,656	$ 12	18,644
Issuance of common stock under the employee stock purchase plan (in shares)		32
Issuance of common stock under the employee stock purchase plan	1,758		1,758
Stock-based compensation	34,781		34,781
Cash dividends declared	(2,550)		(2,550)
Other comprehensive income (loss)	(4,173)				(4,173)
Net (loss)	$ (12,124)			(12,124)
Balance, end of period (in shares) at Mar. 31, 2024	85,011	85,011
Balance, end of period at Mar. 31, 2024	$ 390,186	$ 850	$ 432,217	$ (20,829)	$ (22,052)